Hologic, Inc. (NASDAQ: HOLX) is kicking off Breast Cancer Awareness Month with the announcement that the Company's groundbreaking 3D mammography exam, available on the Selenia Dimensions platform, will be introduced to consumers today as Genius 3D Mammography. Hologic’s Genius 3D Mammography is the only 3D exam approved by the FDA as clinically superior to traditional mammography.
To view the Multimedia News Release, go to http://www.multivu.com/players/English/7254155-hologic-new-consumer-awareness-campaign-mammography-technology/
Hologic, Inc. (Hologic or the Company) (Nasdaq: HOLX), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, has announced the first nine U.S. cities for a series of evening events to introduce clinicians to the Selenia Dimensions 2D/3D breast tomosynthesis system and gain hands-on experience with this new technology.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/hologic/50094/
Hologic, Inc. (Hologic or the Company) (Nasdaq: HOLX), a leading developer, manufacturer and supplier of premium diagnostics products, medical imaging systems and surgical products dedicated to serving the healthcare needs of women, will showcase its 3D mammography and other new, ready-to-market technologies in women’s imaging at the 21st Annual National Interdisciplinary Breast Center Conference (NCBC) in Las Vegas, Nevada, March 12-16, 2011. The NCBC is a nonprofit membership organization dedicated to excellence in breast healthcare for the general public.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/hologic/39364/
Ann Taylor is proud to support The Breast Cancer Research Foundation® (BCRF) through the sale of the Ann Taylor Cares Card at Ann Taylor stores nationwide during the month of May. In addition, a set of three shades of pink nail polish will be available for purchase. 90% of the purchase price of the Ann Taylor Cares Card and 50% of the purchase price of the nail polish set will be donated to BCRF.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58230-ann-taylor-shop-support-breast-cancer-research-foundation-pink-nail-polish
Researchers presenting at ASTRO 2015, the premier radiation oncology scientific event in the world, unveiled new data this week that could fundamentally change the way that early stage breast cancer is treated.
Results from a landmark prospective, randomized, multicenter phase III study conducted in Europe demonstrated that APBI brachytherapy leads to equivalent overall survival and local cancer control rates as compared to WBI after breast conserving surgery for selected patients with early stage breast cancers. These data were presented during the ASTRO official press conference and published in The Lancet, a leading high-impact global peer-reviewed medical journal.
“We have been confidently offering APBI brachytherapy to selected women for years based on numerous phase II, single site and large registry studies that have confirmed the clinical utility of site-specific radiation delivered in a condensed timeframe,” said Frank A. Vicini, M.D., radiation oncologist, 21st Century Oncology, Royal Oak, Mich. and contributing author to the 2009 and 2013 ASTRO and ABS APBI guidelines. “The results from this landmark, multicenter, prospective randomized clinical study are the first to offer the critical level one evidence necessary to drive the fundamental changes in breast conserving cancer treatment that patients and healthcare professionals have been demanding for years.”
To view the multimedia release go to:
http://www.multivu.com/players/uk/7661231-new-apbi-brachytherapy-data-at-astro-2015/
Fergie, six-time Grammy Award winner and Avon spokesperson, was a special guest at the eighth annual Los Angeles-area Avon Walk for Breast Cancer in Santa Barbara, CA, on September 11-12. The Avon Walk raised more than $6.4 million to advance access to care and breast cancer research, and attracted more than 2,800 participants from 45 states and Canada, including 322 breast cancer survivors.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/avon/42977/
Fergie, eight-time Grammy Award winner and global ambassador for the Avon Foundation for Women, was a special guest at the tenth annual Southern California Avon Walk for Breast Cancer in Santa Barbara, CA, on September 22-23. The Avon Walk Santa Barbara, the seventh of nine Avon Walks this year, raised more than $4.7 million to advance access to care and breast cancer research.
To view Multimedia News Release, go to http://www.multivu.com/mnr/58224-fergie-joins-thousands-at-avon-walk-for-breast-cancer-santa-barbara
